BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1226 related articles for article (PubMed ID: 19173686)

  • 1. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D
    Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey.
    Taneja R; Fernandes P; Marwaha G; Cheng D; Bainbridge D
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):662-9. PubMed ID: 18922420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies.
    Arora RC; Légaré JF; Buth KJ; Sullivan JA; Hirsch GM
    Ann Thorac Surg; 2004 Nov; 78(5):1547-54. PubMed ID: 15511428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study.
    Ak K; Isbir CS; Tetik S; Atalan N; Tekeli A; Aljodi M; Civelek A; Arsan S
    J Card Surg; 2009; 24(4):404-10. PubMed ID: 19583608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
    Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
    Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G; Sartipy U; Ivert T; van der Linden J
    Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization.
    Strouch ZY; Drum ML; Chaney MA
    J Clin Anesth; 2009 Nov; 21(7):502-7. PubMed ID: 20006258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
    Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
    Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.